Jasper Therapeutics股價上漲；該公司宣佈與Kira Pharma進行全股票合併

路透中文

07/17

BUZZ-<a href="https://laohu8.com/S/JSPR">Jasper Therapeutics</a>股價上漲；該公司宣佈與Kira Pharma進行全股票合併

7月16日 - ** 生物技術公司Jasper Therapeutics（JSPR.O）的股價在盤後交易中上漲43%，至1.12美元

** JSPR表示，已通過全股票交易完成了對私營公司Kira Pharmaceuticals的收購

** 合併後的公司將專注於開發免疫相關疾病的治療方案，包括Kira用於治療罕見血液疾病和腎臟疾病的領先候選藥物KP-104、Jasper的briquilimab項目以及Kira處於臨床前階段的KP-701抗體項目

** 若Jasper能在2028年12月31日前獲得並變現briquilimab的優先審查憑證，現有Jasper股東將獲得一份不可轉讓的CVR，該憑證與潛在的3000萬美元總付款掛鉤

** Jasper表示，Kira已將其兩個候選藥物KP-301和KP-402授權給Mirador Therapeutics，獲得1200萬美元預付款，外加潛在的研發和銷售里程碑付款

** 截至上一交易日收盤，JSPR股票今年以來累計下跌57%

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2652420390"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2652420390\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2652420390?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-17 06:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652420390","market":"hk","top_or_hot":-1,"title":"Jasper Therapeutics股價上漲；該公司宣佈與Kira Pharma進行全股票合併","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/JSPR\">Jasper Therapeutics</a>股價上漲；該公司宣佈與Kira Pharma進行全股票合併</title></head><body><p><span>7月16日</span><span> - </span>** <a href=\"https://laohu8.com/S/000504\">生物</a>技術公司Jasper <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>（<span>JSPR.O</span>）的股價在盤後交易中上漲43%，至1.12美元 </p><p>** JSPR表示，已通過全股票交易<span>完成了</span>對私營公司Kira Pharmaceuticals的收購</p><p>** 合併後的公司將專注於開發免疫相關疾病的治療方案，包括Kira用於治療罕見血液疾病和腎臟疾病的領先候選藥物KP-104、Jasper的briquilimab項目以及Kira處於臨床前階段的KP-701抗體項目</p><p>** 若Jasper能在2028年12月31日前獲得並變現briquilimab的優先審查憑證，現有Jasper股東將獲得一份不可轉讓的CVR，該憑證與潛在的3000萬美元總付款掛鉤</p><p>** Jasper表示，Kira已將其兩個候選藥物KP-301和KP-402授權給Mirador Therapeutics，獲得1200萬美元預付款，外加潛在的研發和銷售里程碑付款</p><p>** 截至上一交易日收盤，JSPR股票今年以來累計下跌57% </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jasper Therapeutics股價上漲；該公司宣佈與Kira Pharma進行全股票合併</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJasper Therapeutics股價上漲；該公司宣佈與Kira Pharma進行全股票合併\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time smaller\">2026-07-17 06:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/JSPR\">Jasper Therapeutics</a>股價上漲；該公司宣佈與Kira Pharma進行全股票合併</title></head><body><p><span>7月16日</span><span> - </span>** <a href=\"https://laohu8.com/S/000504\">生物</a>技術公司Jasper <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>（<span>JSPR.O</span>）的股價在盤後交易中上漲43%，至1.12美元 </p><p>** JSPR表示，已通過全股票交易<span>完成了</span>對私營公司Kira Pharmaceuticals的收購</p><p>** 合併後的公司將專注於開發免疫相關疾病的治療方案，包括Kira用於治療罕見血液疾病和腎臟疾病的領先候選藥物KP-104、Jasper的briquilimab項目以及Kira處於臨床前階段的KP-701抗體項目</p><p>** 若Jasper能在2028年12月31日前獲得並變現briquilimab的優先審查憑證，現有Jasper股東將獲得一份不可轉讓的CVR，該憑證與潛在的3000萬美元總付款掛鉤</p><p>** Jasper表示，Kira已將其兩個候選藥物KP-301和KP-402授權給Mirador Therapeutics，獲得1200萬美元預付款，外加潛在的研發和銷售里程碑付款</p><p>** 截至上一交易日收盤，JSPR股票今年以來累計下跌57% </p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0070302665.USD","symbol_name":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1Z2:1","article_id":"2652420390","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652420390","pubTimestamp":1784239561,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Jasper Therapeutics股價上漲；該公司宣佈與Kira Pharma進行全股票合併7月16日-** 生物技術公司Jasper Therapeutics（JSPR.O）的股價在盤後交易中上漲43%，至1.12美元** JSPR表示，已通過全股票交易完成了對私營公司Kira Pharmaceuticals的收購** 合併後的公司將專注於開發免疫相關疾病的治療方案，包括Kira用","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","SG9999001424.SGD":"United E-Commerce Fund SGD","HK0000819398.USD":"BLACKROCK PREMIER SYSTEMATIC GLOBAL EQUITY HIGH INCOME FUND A10 (USD)INC","BK4579":"人工智能","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","CIBR":"First Trust NASDAQ Cybersecurity ETF","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","LU2247934214.USD":"FIDELITY FUNDS SUSTAINABLE FUTURE CONNECTIVITY \"A\" (USD) ACC","LU1032955483.USD":"NORDEA 1 STABLE RETURN \"HB\" (USDHDG) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","AIQ":"Global X Artificial Intelligence & Technology ETF","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","CSCO":"思科","BK4581":"高盛持仓","BK4527":"明星科技股","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","CSCL":"2倍做多CSCO ETF-Direxion","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","IYZ":"电信业ETF-iShares","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","SG9999002232.USD":"Allianz Global High Payout USD","CSCS":"1倍做空CSCO ETF-Direxion","BK4534":"瑞士信贷持仓","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","JSPR":"Jasper Therapeutics"},"translate_title":"Jasper Therapeutics Shares Rise; The Company Announces All-Stock Merger with Kira Pharma","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CIBR":0.6,"CSCL":0.6,"IYZ":0.6,"AIQ":0.6,"CSCS":0.6,"CSCO":0.9,"JSPR":0.9},"content_text":"BUZZ-<a href=\"https://laohu8.com/S/JSPR\">Jasper Therapeutics</a>股價上漲；該公司宣佈與Kira Pharma進行全股票合併7月16日 - ** 生物技術公司Jasper Therapeutics（JSPR.O）的股價在盤後交易中上漲43%，至1.12美元 ** JSPR表示，已通過全股票交易完成了對私營公司Kira Pharmaceuticals的收購** 合併後的公司將專注於開發免疫相關疾病的治療方案，包括Kira用於治療罕見血液疾病和腎臟疾病的領先候選藥物KP-104、Jasper的briquilimab項目以及Kira處於臨床前階段的KP-701抗體項目** 若Jasper能在2028年12月31日前獲得並變現briquilimab的優先審查憑證，現有Jasper股東將獲得一份不可轉讓的CVR，該憑證與潛在的3000萬美元總付款掛鈎** Jasper表示，Kira已將其兩個候選藥物KP-301和KP-402授權給Mirador Therapeutics，獲得1200萬美元預付款，外加潛在的研發和銷售里程碑付款** 截至上一交易日收盤，JSPR股票今年以來累計下跌57%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}